*Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt, Germany
†Department of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
‡Department of Anesthesiology, Intensive Care and Pain Medicine, University of Muenster, Muenster, Germany
§Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany
¶Department of Medicine, Institute of Biostatistics and Mathematical Modelling, Goethe University Frankfurt, Germany
||German Red Cross Blood Transfusion Service Baden-Wuerttemberg – Hessen, Institute of Transfusion Medicine and Immunohematology, Frankfurt, Germany
**Central Laboratory, University Hospital Frankfurt, Germany
††Institute of Experimental Hematology and Transfusion Medicine, University of Bonn, Bonn, Germany
‡‡Institute of Transfusion Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
§§Institute of Transfusion Medicine and Transplantation Immunology, University Hospital of Muenster, Muenster, Germany.
Reprints: Patrick Meybohm, MD, MHBA, Kai Zacharowski, MD, PhD, FRCA, Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. E-mail: [email protected].
Disclosure: This work is supported by internal departmental funding of each center and by research grants provided by B. Braun Melsungen AG, Melsungen, Germany; CSL Behring, Marburg, Germany; Fresenius Kabi, Bad Homburg, Germany; and Vifor Pharma Deutschland GmbH, Muenchen, Germany. The Funders of the study had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the article. Independence of researchers from funders is confirmed.
P.M. and K.Z. report unrestricted grant for the PBM study and speakers honoria from Vifor Pharma Deutschland GmbH, München, Germany; B. Braun Melsungen AG, Melsungen, Germany; CSL Behring, Marburg, Germany; and Fresenius Kabi, Bad Homburg, Germany. A.U.S., H.V.A., M.W., G.B., M.G., J.R., E.H., J.R., and D.B. report grants from the University Hospital Frankfurt during the conduct of the study.
D.F. reports speakers honoria from CSL Behring, Vifor Pharma, MSD Sharp & Dohme, Biomet, and grants from Boehringer Ingelheim and B. Braun outside the submitted work. M.G. reports personal fees from Fresenius Medical Care, grants, and personal fees from GE Healthcare, grants from Air Liquide, grants from Paion, personal fees from Edwards Lifesciences, and personal fees from Maquet/Pulsion, outside the submitted work. C.W: reports speakers honoria from TEM International, Verum Diagnostica, csl Behring and Roche AG, outside the submitted work. J.O. reports grants and personal fees from Baxalta, grants and personal fees from Bayer, grants and personal fees from Biotest, grants and personal fees from CSL Behring, grants and personal fees from Grifols, grants and personal fees from Octapharma, personal fees from Novo Nordisk, grants and personal fees from Pfizer, personal fees from Chugai, personal fees from Roche, and personal fees from SOBi, outside the submitted work.
The authors declare no conflicts of interests.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.annalsofsurgery.com).
